News & Insights
July 31, 2025 K&S secures a complete defense verdict on behalf of CG Oncology in a dispute with ANI Pharmaceuticals over future royalties on net sales of cretostimogene or, in the alternative, $2.3B in unjust enrichment damages
July 29, 2025 King & Spalding Secures Complete Defense Verdict for CG Oncology in Defense of Future Royalties and $2.3 Billion Unjust Enrichment Claim
April 24, 2017 King & Spalding’s Austin Office Adds Three Tort Litigation Partners